Summary
- Profile Type
- Technology request
- POD Reference
- TRGR20241029011
- Term of Validity
- 29 October 2024 - 29 October 2025
- Company's Country
- Greece
- Type of partnership
- Research and development cooperation agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A Greek biotech company has developed an innovative Distributed Ledger Technology (DLT) marketplace (AI-MetaBloQ), aiming to create a secure platform for biospecimens and data sharing among healthcare stakeholders. The company is looking for European end-users (biobanks, hospitals, patients, researchers) for usability studies and pilot testing under a research and development cooperation agreement.
- Full Description
-
The Greek biotech company designs, delivers, and implements IT solutions for established biobanks, integrating data from all entities within the biosample value chain. The company innovates in biosample annotation, optimizes the drug development cycle, and provides tools for personalized medicine by connecting all stakeholders in the biosample usage chain, enriching biosample data, and creating networks with advanced, research-friendly query tools.
AI-MetaBloQ is an innovative system, part of the company’s R&D projects, being a part of EU funded project within the framework of NGI Trustchain OC3 open calls initiatives. It is a groundbreaking DLT (Distributed Ledger Technology) web marketplace, which facilitates secure data sharing among biobanks, researchers, hospitals and patients, disseminating biosamples and related data while ensuring compliance and privacy through decentralized digital identities and robust encryption.
AI-MetaBloQ sets a new industry standard by enabling patients to control and monetize their biological data anonymously, ensuring trust and data immutability. Powered by Reactive AI, it provides advanced Quality Management for biological samples, automatically assessing and ranking biospecimens based on real-time data to optimize research. The platform enhances research efficiency through AI-driven analysis and strict quality standards. The DLT marketplace offers a secure, transparent platform for exchanging health data using blockchain, transforming digital health and research.
The system ensures data security by allowing only authorized access with permission for each transaction, and enables monetization by letting users earn or exchange services for their data. It maintains transparency with an immutable record of all transactions, giving users control over who can access their data and for what purposes. Additionally, it supports multi-source enrollment and compliance, allowing users to interact with various stakeholders while adhering to regulatory and legal standards.
The company is looking for European end-users, including biobanks, hospitals, patients, and researchers, to participate in usability studies and pilot testing as part of a research and development cooperation agreement. By engaging directly with end-users, the company can gather valuable feedback to refine AI-MetaBloQ's features and functionality, ensuring they meet the diverse needs of all stakeholders. The goal is to address any challenges, enhance user experience and create an intuitive and effective platform that fosters seamless interactions and data exchanges while maintaining the highest standards of security and compliance. - Advantages and Innovations
-
The product will foster the development of international social networks and enhance communication among research teams, industry, biobanks, and health service providers, creating new opportunities for synergies and collaboration. By providing the infrastructure for interoperable communication and real-time data exchange across the network, the company aims to showcase its solution's international potential. This patient-centric approach seeks to establish strong collaborative networks within the biobanking and clinical sectors.
No current solution provides comprehensive, interoperable data across clinical, molecular, genetic, pre-analytical, environmental, and disorder development sources. AI-MetaBloQ integrates longitudinal data for each patient and their biospecimens. Users, including patients, hospitals, and researchers, contribute and enrich the system. Patients earn commissions for their samples or participation in clinical trials, while researchers and biobanks can collaborate through open or targeted invitations. Hospitals can support personalized medicine by sharing data securely. The decentralized marketplace introduces data sharing and governance, creating win-win scenarios for all participants. - Stage of Development
- Under development
- Sustainable Development Goals
- Goal 9: Industry, Innovation and Infrastructure
- Goal 3: Good Health and Well-being
- IPR description
- European representatives from each key user group—biobanks, hospitals, patients, and researchers—are sought for participation in usability studies and final pilot testing. These representatives will be responsible for providing in-depth user assessments and validating the product throughout the deployment and final testing phases before market release.
Partner Sought
- Expected Role of a Partner
- The company aims to collaborate with European representatives from each user type (biobank, hospital, patient, researcher), for usability studies and final pilot testing under a research and development cooperation agreement. This collaboration will allow for thorough user assessment and product validation during both the deployment phase and the final testing phase before market release. Selected partners will receive free 12-month access to the innovative DLT (Distributed Ledger Technology) marketplace, AI-MetaBloQ, following its market release.
- Type and Size of Partner
- Other
- University
- R&D Institution
- Type of partnership
- Research and development cooperation agreement
Dissemination
- Technology keywords
- 01004001 - Applications for Health
- 01003008 - Data Processing / Data Interchange, Middleware
- 06005003 - Health information management
- Market keywords
- 02007012 - Medical/health software
- 05007007 - Other medical/health related (not elsewhere classified)
- 02006004 - Data processing, analysis and input services
- 05005021 - Medical computer sciences
- Sector Groups Involved
- Health
- Digital
- Targeted countries
- All countries